Top Biotech Companies (3,709)
Qubit Pharmaceuticals is a physics-driven drug discovery company developing lifesaving treatments through quantum-accurate computational methods. It combines advanced simulation software, hybrid quantum-classical computing, and AI-enhanced medicinal chemistry to design novel drug candidates atom by atom. Its platform targets challenging diseases by optimizing candidate efficacy, specificity, and safety, aiming to accelerate the development of innovative therapies for patients with serious unmet...
Atavistik Bio is a new, privately-held biopharmaceutical company focused on the discovery and development of novel therapies for metabolic diseases and cancer. Our high-throughput platform for the unbiased identification of metabolite-protein interactions will enable the discovery of first-in-class drugs inspired and empowered by nature’s own mechanisms of allosteric control. Our unique approach marries this validated platform with structure-aided drug design...
Bavarian Nordic is a global biotechnology company focused on the development, manufacturing, and commercialization of innovative vaccines, with a mission to improve health and save lives.
Maravai brands set the standard in nucleic acid products and services, enzyme development, and biologics safety testing. From producing revolutionary mRNA technologies that drive infectious disease vaccines, cancer vaccines, and other cell and gene therapies to delivering gold-standard bioprocess impurity detection solutions, Maravai is helping life sciences companies overcome their biggest development and manufacturing challenges to streamline and scale from...
Gerresheimer is the global partner for pharma, biotech, healthcare and cosmetics with a very broad product range for pharmaceutical and cosmetic packaging and drug delivery devices. The company is an innovative solution provider from concept to delivery of the end product. Gerresheimer achieves its ambitious goals through a high level of innovative strength, industrial competence, focus on quality and customers....
Sana Biotechnology is focused on utilizing engineered cells as medicines for patients. The ability to modify genes and use cells as medicines will be one of the most important advances in healthcare over the next several decades. Sana is building differentiated capabilities across the spectrum of cell and gene therapy. Three aspirations drive Sana as we look to discover...
Helaina is a biotech company pushing the boundaries of what food can do for health.
Helaina's Top Stability & Growth Strengths
Investor Backing & Capital Strength: The company closed a $45M Series B in 2024 (total equity reportedly ~$83M), explicitly to accelerate commercialization and scale production. This capital supports moving from R&D to commercial supply at metric‑ton levels and “10 million servings per run.”
Strategic Partnerships: Named distributor and brand relationships (e.g., Mitsubishi International Food Ingredients, Kroma Wellness, The Feed, Levelle, Healthgevity) and a reported multiyear Nestlé collaboration signal commercial pathways and validation. By late 2025 the company cited work with over half a dozen partners developing products featuring its ingredient.
Strong Market Position & Advantage: Within human‑identical lactoferrin produced via precision fermentation, the firm is portrayed as a front‑runner with first‑to‑market claims, commercial‑scale manufacturing, and an unusual depth of peer‑reviewed safety and characterization work. Trade coverage frequently cites it as a standard‑bearer broadening use cases beyond infant formula into women’s health, immunity, and gut health.
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions, lab testing, and advisory services for the healthcare industry. Driven by its mission of Safeguarding Global Health®, the company operates through three primary businesses—Sterigenics, Nordion, and Nelson Labs—serving the medical device, pharmaceutical, tissue, and food industries to ensure the safety of patients and healthcare practitioners worldwide.
Velocity Bioworks is a U.S.-based biopharma CDMO and a wholly owned subsidiary of Valion Bio, Inc., headquartered in San Antonio, Texas. It provides bioprocess development, GMP biomanufacturing, analytical testing, and other services for biologics, supporting both internal pipelines and third-party clients.
Trusted by the world's leading organizations, Point B is a consulting firm that works at the intersection of expertise, industry insight, and transformative technology. This collaborative approach enables you to solve your most important challenges, by bringing together the right mix of talent and technology to deliver greater value and impact. With over 850 associates in the US and 3000+...
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with...
Roche's Top Stability & Growth Strengths
Strong Market Position & Advantage: Roche is the global leader in in‑vitro diagnostics and remains a top‑tier biopharma with a significant oncology footprint. The dual Pharmaceuticals–Diagnostics model is a strategic differentiator at scale.
Strong Revenue Growth: Group sales rose 7% at constant exchange rates in 2025 and 6% at CER in Q1 2026, with both divisions contributing. Guidance for 2026 indicates continued mid–single‑digit CER growth.
Profitability: Profitability improved in 2025 alongside sales, with higher IFRS net income and core EPS growth. Management pointed to capacity to keep investing while rewarding shareholders.
The Medical College of Wisconsin brings a synergy between the best medical education, research and patient care.
Varda Space Industries was founded in 2020 with the goal of manufacturing products in space to benefit life on Earth. Co-founders Will Bruey and Delian Asparouhov imagined a world where space could be leveraged not only for storytelling and awe, but for its economic benefits. Varda was created as a platform for in-space manufacturing, with a range of real-life, on-Earth...
.png)
Ancestry is the global leader in family history and consumer genomics. Every day, around the world, we help curious people like you embark on journeys of personal discovery to enrich lives. With our unparalleled collection of more than 40 billion records from more than 80 countries and 23+ million people in our growing DNA network, Ancestry helps customers discover their family...
Ancestry's Top Stability & Growth Strengths
Strong Market Position & Advantage: Company communications and industry coverage consistently depict Ancestry as the category leader, citing tens of billions of records, millions of subscribers, and the world’s largest consumer DNA network. Blackstone’s 2020 acquisition and a weakened rival landscape (e.g., 23andMe’s 2025 bankruptcy) reinforce its durable leadership.
Product Line Growth: Content and features expanded with 243 new historical collections in 2025, the largest-ever ethnicity update, and the iMemories acquisition adding media digitization. AI-enabled processing accelerates turning archives into searchable data, signaling ongoing product and data-scale growth.
Market Expansion: The company launched services in Italy and the Netherlands in 2025 and reported strong subscriber scale alongside rising community uploads. A multiyear partnership with the U.S. National Archives supports continued content expansion that benefits multiple markets.
A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancer. Ratio Therapeutics’ Trillium™ targeting scaffold combines pharmacokinetic modulation with best-in-class chelation technology to create proprietary small molecule targeting agents to attack a broad array of cancer targets. Our compounds accommodate imaging and therapeutic radioisotopes, ie...
Founded in 1910 as a pediatric dental hospital for underserved children in Boston, the ADA Forsyth Institute is a world-leading independent research institution focused on oral health and its connection to overall wellness. Its mission encompasses biological research, clinical service, and public health outreach, including the ForsythKids mobile dental program, to improve global oral health through cutting-edge research and innovative...
Prelude Therapeutics Incorporated is a clinical-stage precision oncology company dedicated to discovering and developing innovative, novel precision cancer medicines for underserved patients. The company focuses on targeting key drivers of cancer cell growth and resistance, with a pipeline that includes JAK2V617F and KAT6A programs and degrader antibody conjugates to treat various cancers, including breast cancer and myeloproliferative neoplasms.
BioPharma Consulting JAD Group provides a complete portfolio of technical support and solutions for the FDA regulated industry. We deliver solutions with a flexible cost effective approach to meet your company’s needs. BPC JAD group is a company created to help our customers bridge the gap between their business strategy and results. Our mission is to help our clients succeed by...
Kernal Biologics is a biotechnology company developing mRNA therapies that instruct specific cells to produce their own medicine, targeting diseases such as cancer and autoimmune disorders.
Leading the field in the discovery of drugs that modulate the effects of cortisol. The adverse effects of excess cortisol have been Corcept’s focus since the company’s inception. Abnormal levels and release of cortisol play a role in a variety of metabolic, oncological, and psychiatric diseases, and we are currently studying a new generation of compounds that may mitigate the effects...
